CDC Vaccine Panel Presentation Distorts Research on Safety of mRNA COVID-19 Vaccines
A retrospective study found mRNA vaccines from Pfizer and Moderna improved survival in lung cancer and melanoma patients by enhancing immune response during immunotherapy.
8 Articles
8 Articles
CDC Vaccine Panel Presentation Distorts Research on Safety of mRNA COVID-19 Vaccines
A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel highlighted various alleged “safety uncertainties” of the mRNA COVID-19 vaccines, including those about cancer and changes to the immune system. Scientists, however, told us that many of the cited studies are either misconstrued or of poor quality. As with all medical products, the mRNA COVID-19 vaccines are not 100% safe. Bu…
Together, mRNA vaccine and immunotherapy could double the survival of cancer patients – a breakthrough in the field of oncology and the fight against cancer.
By stimulating the immune system, the Covid-19 mRNA vaccine produced an unexpected effect: it boosted the anti-tumour response of patients with advanced cancers. A lead towards a future cancer vaccine?
Study Reveals COVID-19 Vaccines May Help Strengthen Cancer Treatment - THE DESTINATION
WASHINGTON — In a groundbreaking discovery, U.S. scientists have found that COVID-19 mRNA vaccines may aid in cancer treatment by strengthening the body’s immune system, according to new research. The study, reported by CNN, revealed that mRNA vaccines — originally developed to prevent COVID-19 — could also benefit cancer patients by boosting their immune response and […] The post Study Reveals COVID-19 Vaccines May Help Strengthen Cancer Treatm…
Study Finds COVID mRNA Shots Could Improve Cancer Treatment Outcomes - Mahomet Daily
Cancer patients with advanced lung and skin cancers who received COVID-19 mRNA vaccines during immunotherapy treatment lived substantially longer than those who didn’t, according to groundbreaking research presented at the 2025 European Society for Medical Oncology Congress in Berlin and published in the journal Nature. The study, led by researchers at the University of Texas MD Anderson Cancer Center and the University of Florida, analyzed med…
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium



